Symbols / WRBY Stock $23.06 -6.18% Warby Parker Inc.

Healthcare • Medical Instruments & Supplies • United States • NYQ
WRBY (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Stock Fundamentals
Scroll to Statements
Market Cap 2.82B Enterprise Value 2.96B Income 1.64M Sales 871.91M Book/sh 3.00 Cash/sh 2.34
Dividend Yield — Payout 0.00% Employees 2275 IPO — P/E 2306.00 Forward P/E 34.14
PEG — P/S 3.24 P/B 7.68 P/C — EV/EBITDA 64.98 EV/Sales 3.39
Quick Ratio 1.93 Current Ratio 2.35 Debt/Eq 63.40 LT Debt/Eq — EPS (ttm) 0.01 EPS next Y 0.68
EPS Growth — Revenue Growth 11.20% Earnings 2026-05-07 ROA -0.43% ROE 0.46% ROIC —
Gross Margin 53.97% Oper. Margin -4.54% Profit Margin 0.19% Shs Outstand 106.77M Shs Float 92.20M Short Float 10.81%
Short Ratio 3.90 Short Interest — 52W High 31.00 52W Low 14.77 Beta 2.08 Avg Volume 2.92M
Volume 669.16K Target Price $29.17 Recom Buy Prev Close $24.58 Price $23.06 Change -6.18%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$29.17
Mean price target
2. Current target
$23.06
Latest analyst target
3. DCF / Fair value
$5.50
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$23.06
Low
$24.00
High
$35.00
Mean
$29.17

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-17 main Citigroup Neutral → Neutral $24
2026-02-20 main Telsey Advisory Group Outperform → Outperform $32
2026-02-10 main Telsey Advisory Group Outperform → Outperform $32
2025-12-16 main Piper Sandler Overweight → Overweight $32
2025-12-12 main Stifel Hold → Hold $25
2025-12-11 main BTIG Buy → Buy $32
2025-11-18 main Telsey Advisory Group Outperform → Outperform $24
2025-11-07 main UBS Neutral → Neutral $20
2025-11-07 main Telsey Advisory Group Outperform → Outperform $24
2025-11-06 main BTIG Buy → Buy $25
2025-10-31 main Telsey Advisory Group Outperform → Outperform $28
2025-10-28 reit BTIG Buy → Buy $28
2025-10-06 main Goldman Sachs Buy → Buy $31
2025-08-08 main UBS Neutral → Neutral $23
2025-08-08 main Stifel Hold → Hold $22
2025-08-08 main Telsey Advisory Group Outperform → Outperform $28
2025-08-07 main Telsey Advisory Group Outperform → Outperform $28
2025-08-07 main BTIG Buy → Buy $28
2025-08-01 main Telsey Advisory Group Outperform → Outperform $28
2025-07-30 main Baird Outperform → Outperform $30
News
RSS: Latest WRBY news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-20 BLUMENTHAL NEIL HARRIS Chief Executive Officer — 100,000 $24.08 $2,467,130
2026-04-20 BLUMENTHAL NEIL HARRIS Chief Executive Officer — 100,000 — —
2026-03-11 RAIDER JEFFREY JACOB Director — 25,000 $25.43 $635,750
2026-03-05 BLUMENTHAL NEIL HARRIS Chief Executive Officer — 13,475 — —
2026-03-05 GILBOA DAVID ABRAHAM Chief Executive Officer — 13,475 — —
2026-03-04 SINGER BRADLEY E Director — 15,793 $27.53 $434,781
2026-03-02 BLUMENTHAL NEIL HARRIS Chief Executive Officer — 15,967 $0.00 $0
2026-03-02 GILBOA DAVID ABRAHAM Chief Executive Officer — 15,967 $0.00 $0
2026-01-13 BLUMENTHAL NEIL HARRIS Chief Executive Officer — 660 $29.99 $19,793
2026-01-13 BLUMENTHAL NEIL HARRIS Chief Executive Officer — 660 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
871.90
+13.04%
771.32
+15.16%
669.76
+11.98%
598.11
Operating Revenue
871.90
+13.04%
771.32
+15.16%
669.76
+11.98%
598.11
Cost Of Revenue
401.33
+16.50%
344.48
+13.11%
304.54
+18.48%
257.05
Reconciled Cost Of Revenue
401.33
+16.50%
344.48
+13.11%
304.54
+18.48%
257.05
Gross Profit
470.58
+10.25%
426.83
+16.87%
365.22
+7.08%
341.06
Operating Expense
475.92
+4.15%
456.95
+4.51%
437.22
-3.33%
452.26
Selling General And Administration
475.92
+4.15%
456.95
+4.51%
437.22
-3.33%
452.26
Total Expenses
877.24
+9.46%
801.43
+8.04%
741.76
+4.57%
709.32
Operating Income
-5.34
+82.28%
-30.11
+58.18%
-72.00
+35.26%
-111.20
Total Operating Income As Reported
-5.34
+82.28%
-30.11
+58.18%
-72.00
+35.26%
-111.20
EBITDA
44.94
+185.30%
15.75
+147.11%
-33.44
+57.85%
-79.34
Normalized EBITDA
44.94
+185.30%
15.75
+147.11%
-33.44
+57.85%
-79.34
Reconciled Depreciation
50.28
+9.63%
45.87
+18.96%
38.55
+21.00%
31.86
EBIT
-5.34
+82.28%
-30.11
+58.18%
-72.00
+35.26%
-111.20
Net Income
1.64
+108.05%
-20.39
+67.74%
-63.20
+42.75%
-110.39
Pretax Income
3.04
+115.59%
-19.52
+68.91%
-62.76
+42.89%
-109.90
Net Non Operating Interest Income Expense
8.38
-20.93%
10.60
+14.79%
9.23
+606.35%
1.31
Net Interest Income
8.38
-20.93%
10.60
+14.79%
9.23
+606.35%
1.31
Tax Provision
1.40
+60.23%
0.88
+102.08%
0.43
-12.88%
0.50
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
1.64
+108.05%
-20.39
+67.74%
-63.20
+42.75%
-110.39
Net Income From Continuing Operation Net Minority Interest
1.64
+108.05%
-20.39
+67.74%
-63.20
+42.75%
-110.39
Net Income From Continuing And Discontinued Operation
1.64
+108.05%
-20.39
+67.74%
-63.20
+42.75%
-110.39
Net Income Continuous Operations
1.64
+108.05%
-20.39
+67.74%
-63.20
+42.75%
-110.39
Normalized Income
1.64
+108.05%
-20.39
+67.74%
-63.20
+42.75%
-110.39
Net Income Common Stockholders
1.64
+108.05%
-20.39
+67.74%
-63.20
+42.75%
-110.39
Diluted EPS
—
-0.17
+68.52%
-0.54
+43.75%
-0.96
Basic EPS
—
-0.17
+68.52%
-0.54
+43.75%
-0.96
Basic Average Shares
—
120.39
+2.55%
117.39
+2.13%
114.94
Diluted Average Shares
—
120.39
+2.55%
117.39
+2.13%
114.94
Diluted NI Availto Com Stockholders
1.64
+108.05%
-20.39
+67.74%
-63.20
+42.75%
-110.39
Preferred Stock Dividends
—
—
—
—
Total Other Finance Cost
-8.38
+20.93%
-10.60
-14.79%
-9.23
-606.35%
-1.31
Line Item Trend 2023-12-31
Total Assets
580.31
Current Assets
298.62
Cash Cash Equivalents And Short Term Investments
216.89
Cash And Cash Equivalents
216.89
Receivables
1.78
Accounts Receivable
1.78
Inventory
62.23
Prepaid Assets
—
Other Current Assets
17.71
Total Non Current Assets
281.69
Net PPE
274.64
Gross PPE
390.47
Accumulated Depreciation
-115.84
Properties
0.00
Machinery Furniture Equipment
88.89
Construction In Progress
17.55
Other Properties
122.31
Leases
161.72
Other Non Current Assets
7.06
Total Liabilities Net Minority Interest
278.52
Current Liabilities
127.09
Payables And Accrued Expenses
68.78
Payables
22.46
Accounts Payable
22.46
Current Accrued Expenses
46.32
Current Debt And Capital Lease Obligation
24.29
Current Capital Lease Obligation
24.29
Current Deferred Liabilities
31.62
Current Deferred Revenue
31.62
Other Current Liabilities
2.41
Total Non Current Liabilities Net Minority Interest
151.44
Long Term Debt And Capital Lease Obligation
150.17
Long Term Capital Lease Obligation
150.17
Non Current Deferred Liabilities
—
Other Non Current Liabilities
1.26
Stockholders Equity
301.79
Common Stock Equity
301.79
Capital Stock
0.01
Common Stock
0.01
Share Issued
118.16
Ordinary Shares Number
118.16
Treasury Shares Number
0.00
Additional Paid In Capital
970.13
Retained Earnings
-666.83
Gains Losses Not Affecting Retained Earnings
-1.53
Other Equity Adjustments
-1.53
Total Equity Gross Minority Interest
301.79
Total Capitalization
301.79
Working Capital
171.53
Invested Capital
301.79
Total Debt
174.46
Capital Lease Obligations
174.46
Net Tangible Assets
301.79
Tangible Book Value
301.79
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
110.78
+12.19%
98.74
+61.90%
60.99
+488.15%
10.37
Cash Flow From Continuing Operating Activities
110.78
+12.19%
98.74
+61.90%
60.99
+488.15%
10.37
Net Income From Continuing Operations
1.64
+108.05%
-20.39
+67.74%
-63.20
+42.75%
-110.39
Depreciation Amortization Depletion
50.28
+9.63%
45.87
+18.96%
38.55
+21.00%
31.86
Depreciation And Amortization
50.28
+9.63%
45.87
+18.96%
38.55
+21.00%
31.86
Other Non Cash Items
6.23
+5.53%
5.90
-3.06%
6.09
+51.51%
4.02
Stock Based Compensation
34.54
-26.98%
47.29
-32.92%
70.51
-28.08%
98.03
Asset Impairment Charge
0.56
-31.74%
0.82
-74.74%
3.23
+96.11%
1.65
Change In Working Capital
17.55
-8.90%
19.26
+231.54%
5.81
+139.26%
-14.80
Change In Receivables
-1.34
-691.12%
-0.17
+51.01%
-0.34
+23.50%
-0.45
Changes In Account Receivables
-1.34
-691.12%
-0.17
+51.01%
-0.34
+23.50%
-0.45
Change In Inventory
7.83
-20.79%
9.89
+49.52%
6.61
+156.08%
-11.79
Change In Prepaid Assets
-5.63
-74.17%
-3.23
+1.31%
-3.28
+68.90%
-10.53
Change In Payables And Accrued Expense
5.81
-43.10%
10.21
+240.54%
-7.26
-39.85%
-5.20
Change In Accrued Expense
-2.69
-128.26%
9.52
+207.00%
-8.90
-423.80%
2.75
Change In Payable
8.50
+1133.67%
0.69
-57.81%
1.63
+120.56%
-7.94
Change In Account Payable
8.50
+1133.67%
0.69
-57.81%
1.63
+120.56%
-7.94
Change In Other Working Capital
9.78
+267.64%
2.66
-74.53%
10.45
-4.74%
10.97
Change In Other Current Liabilities
1.09
+1198.99%
-0.10
+73.02%
-0.37
-116.61%
2.21
Investing Cash Flow
-67.05
-1.54%
-66.03
-20.78%
-54.67
+9.16%
-60.18
Cash Flow From Continuing Investing Activities
-67.05
-1.54%
-66.03
-20.78%
-54.67
+9.16%
-60.18
Net PPE Purchase And Sale
-67.05
-4.71%
-64.03
-19.30%
-53.67
+10.82%
-60.18
Purchase Of PPE
-67.05
-4.71%
-64.03
-19.30%
-53.67
+10.82%
-60.18
Capital Expenditure
-67.05
-4.71%
-64.03
-19.30%
-53.67
+10.82%
-60.18
Net Business Purchase And Sale
0.00
+100.00%
-2.00
-100.00%
-1.00
0.00
Purchase Of Business
0.00
+100.00%
-2.00
-100.00%
-1.00
0.00
Financing Cash Flow
-12.00
-341.92%
4.96
+72.73%
2.87
-12.76%
3.29
Cash Flow From Continuing Financing Activities
-12.00
-341.92%
4.96
+72.73%
2.87
-12.76%
3.29
Net Issuance Payments Of Debt
—
—
0.00
-100.00%
0.09
Issuance Of Debt
—
—
0.00
-100.00%
0.09
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
0.00
-100.00%
0.09
Net Long Term Debt Issuance
—
—
0.00
-100.00%
0.09
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
—
—
0.00
0.00
Common Stock Payments
—
—
0.00
0.00
Repurchase Of Capital Stock
—
—
0.00
0.00
Proceeds From Stock Option Exercised
2.36
-48.92%
4.63
+61.13%
2.87
-10.28%
3.20
Net Other Financing Charges
-14.36
-4412.31%
0.33
—
0.09
Changes In Cash
31.74
-15.74%
37.67
+309.87%
9.19
+119.76%
-46.52
Effect Of Exchange Rate Changes
0.46
+213.12%
-0.40
+54.20%
-0.88
+32.72%
-1.31
Beginning Cash Position
254.16
+17.18%
216.89
+3.98%
208.59
-18.65%
256.42
End Cash Position
286.36
+12.67%
254.16
+17.18%
216.89
+3.98%
208.59
Free Cash Flow
43.74
+26.00%
34.71
+374.21%
7.32
+114.70%
-49.81
Interest Paid Supplemental Data
0.33
+32.11%
0.25
+8.37%
0.23
+23.37%
0.18
Income Tax Paid Supplemental Data
0.78
-25.02%
1.03
+147.02%
0.42
-21.83%
0.54
Common Stock Issuance
—
—
—
2.74
Issuance Of Capital Stock
—
—
—
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category